GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BSP:GILD34) » Definitions » Other Gross PPE

Gilead Sciences (BSP:GILD34) Other Gross PPE : R$7,278 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Gilead Sciences Other Gross PPE?

Gilead Sciences's Other Gross PPE for the quarter that ended in Dec. 2024 was R$7,278 Mil.

Gilead Sciences's quarterly Other Gross PPE increased from Jun. 2024 (R$28,794 Mil) to Sep. 2024 (R$29,854 Mil) but then declined from Sep. 2024 (R$29,854 Mil) to Dec. 2024 (R$7,278 Mil).

Gilead Sciences's annual Other Gross PPE declined from Dec. 2022 (R$5,822 Mil) to Dec. 2023 (R$5,620 Mil) but then increased from Dec. 2023 (R$5,620 Mil) to Dec. 2024 (R$7,278 Mil).


Gilead Sciences Other Gross PPE Historical Data

The historical data trend for Gilead Sciences's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Other Gross PPE Chart

Gilead Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,650.81 5,383.47 5,822.39 5,620.07 7,278.49

Gilead Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,620.07 26,497.52 28,794.09 29,854.28 7,278.49

Gilead Sciences Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Gilead Sciences Business Description

Address
333 Lakeside Drive, Foster City, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Sciences Headlines

No Headlines